527 results on '"Wu, Runhui"'
Search Results
2. A long term outcomes analysis of severe haemophilia A boys receiving 4 years prophylaxis on the Chinese Haemophilia Individualized escalating low dose Prophylaxis (CHIPS)
3. International Society on Thrombosis and Haemostasis clinical practice guideline for treatment of congenital hemophilia A and B based on the Grading of Recommendations Assessment, Development, and Evaluation methodology
4. Surgical procedures and complications in placement of totally implantable venous access port in pediatric hemophilia patients: A retrospective analysis
5. HIF-1α induced by hypoxic condition regulates Treg/Th17 axis polarization in chronic immune thrombocytopenia
6. Machine learning models developed and internally validated for predicting chronicity in pediatric immune thrombocytopenia
7. Report on diagnosis and treatment of hemophilia in China 2023
8. Machine learning model for predicting physical activity related bleeding risk in Chinese boys with haemophilia A
9. Development and internal validation of a clinical prediction model for individualized dosing of BAY 81-8973, A full-length recombinant factor VIII, in pediatric patients with haemophilia A
10. First Case Report of FOXN1 Haploinsufficiency in China and Literature Review
11. Elevated TCR-αβ+ double-negative T cells in pediatric patients with acquired aplastic anemia
12. Low-dose immune tolerance induction therapy in severe hemophilia a children in China: Starting earlier resulted in better inhibitor eradication outcomes
13. Efficacy and safety of fitusiran prophylaxis in people with haemophilia A or haemophilia B with inhibitors (ATLAS-INH): a multicentre, open-label, randomised phase 3 trial
14. Development and Application of Comprehensive Evaluation System in the Treatment of Children with Hemophilia in China
15. The Progress in Research in Hereditary Thrombotic Thrombocytopenic Purpura in Children
16. Skin Rash as the First Manifestation of Pediatric Chronic Neutrophilic Leukemia
17. Central venous access devices implantation in children with severe hemophilia a: data from the children comprehensive care center of China
18. Babesia microti Causing Intravascular Hemolysis in Immunocompetent Child, China
19. The Differences of Serum Thrombopoietin Levels Between Acquired Aplastic Anemia and Immune Thrombocytopenia in Pediatric Patients
20. Reduced doses of emicizumab achieve good efficacy: Results from a national‐wide multicentre real‐world study in China
21. Low‐dose immune tolerance induction for severe hemophilia A inhibitor patients: Immunosuppressants are generally not necessary for inhibitor‐titer below 200 BU/mL
22. The early and rapid response to daratumumab in children with chronic refractory immune thrombocytopenia from a referral single centre of China
23. F8 gene mutation spectrum in severe hemophilia A with inhibitors: A large cohort data analysis from a single center in China
24. Health-related quality of life in children with chronic myeloid leukemia in the chronic phase
25. Enhanced pharmacokinetics and reduced bleeds in boys with hemophilia A after switching to Kovaltry from other standard half‐life factor VIII concentrates
26. Increased proportion of Th17/Treg cells at the new diagnosed stage of chronic immune thrombocytopenia in pediatrics: the pilot study from a multi-center
27. Efficacy and safety of avatrombopag in Chinese children with persistent and chronic primary immune thrombocytopenia: A multicentre observational retrospective study in China
28. B cell acute lymphoblastic leukemia following mild COVID-19 in an 11-year-old boy
29. Spotlight on eltrombopag concentration in pediatric immune thrombocytopenia: A single‐center observational study in China
30. Maternal Microchimerism Promotes Tolerance Induction Toward Factor VIII in Severe Haemophilia a Children with Inhibitors
31. Spotlight on eltrombopag in pediatric ITP in China: a long-term observational study in real-world practice
32. Cost-effectiveness Analysis of Prophylaxis Versus On-demand Treatment for Children With Hemophilia B Without Inhibitors in China
33. Significant reduction in hemarthrosis in boys with severe hemophilia A: The China hemophilia individualized low‐dose secondary prophylaxis study
34. Low‐dose immune tolerance induction alone or with immunosuppressants according to prognostic risk factors in Chinese children with hemophilia A inhibitors
35. FOXO1 Single-Nucleotide Polymorphisms Are Associated with Bleeding Severity and Sensitivity of Glucocorticoid Treatment of Pediatric Immune Thrombocytopenia.
36. Complete F9 Gene Deletion, Duplication, and Triplication Rearrangements: Implications for Factor IX Expression and Clinical Phenotypes.
37. Sirolimus is effective for primary relapsed/refractory autoimmune cytopenia: a multicenter study
38. Maternal microchimerism protects hemophilia A patients from inhibitor development
39. Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial
40. Long‐term eltrombopag in children with chronic immune thrombocytopenia: A single‐centre extended real‐life observational study in China
41. Chinese Severe Hemophilia a Children with High-Titer Inhibitors Obtain More Benefit from Intermediate-Dose Immune Tolerance Induction: The Interim Result of Lome Part a
42. Complete F9 gene deletion, duplication and triplication rearrangements: implications for factor IX expression and clinical phenotypes
43. Individualized chemotherapy and efficacy analysis of hepatoblastoma in children
44. Oral health status and oral habits of children and adolescents with hemophilia: a report from the children’s hemophilia comprehensive care center of China
45. High-dose dexamethasone as a replacement for traditional prednisone as the first-line treatment in children with previously untreated primary immune thrombocytopenia: a prospective, randomized single-center study
46. A semiquantitative color Doppler ultrasound scoring system for evaluation of synovitis in joints of patients with blood-induced arthropathy
47. Building a network for hemophilia care in China: 15 years of achievement for the Hemophilia Treatment Center Collaborative Network of China
48. Low‐dose immune tolerance induction for children with hemophilia A with poor‐risk high‐titer inhibitors: A pilot study in China
49. In-situ synthesis of MnCo2O4.5 nanosheets on reduced graphene oxide for a great promotion in the thermal decomposition of ammonium perchlorate
50. Impact of prophylaxis on health‐related quality of life of boys with hemophilia: An analysis of pooled data from 9 countries
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.